EcoDrugPlus

Proteasome Subunit Beta Type-11-Like

Ensembl ID : ENSCVAG00000013814
Gene Symbol: LOC107094889
3 Cross references
161 Possible Orthologues:

Proteasome Subunit Beta Type-6-Like

Ensembl ID : ENSCVAG00000017120
Gene Symbol: LOC107104657
3 Cross references
228 Possible Orthologues:

Proteasome Subunit Beta Type-7-Like

Ensembl ID : ENSCVAG00000012309
Gene Symbol: LOC107080947
3 Cross references
172 Possible Orthologues:

Proteasome Subunit Beta Type-9

Ensembl ID : ENSCVAG00000005145
Gene Symbol: LOC107104822
3 Cross references
208 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSCVAG00000006325
Gene Symbol: PRMT5
3 Cross references
199 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSCVAG00000017113
Gene Symbol: LOC107093655
3 Cross references
203 Possible Orthologues:

Protein Kinase C Alpha Type

Ensembl ID : ENSCVAG00000014380
Gene Symbol: LOC107084715
3 Cross references
212 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSCVAG00000022222
Gene Symbol: PRKCB
4 Cross references
211 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSCVAG00000015967
Gene Symbol: LOC107086424
3 Cross references
203 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSCVAG00000005293
Gene Symbol: PRKCD
3 Cross references
205 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSCVAG00000013385
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSCVAG00000005589
Gene Symbol: PRKCE
2 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).